Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

575 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The perceptions of cancer health-care practitioners in New Zealand and the USA toward psychedelic-assisted therapy with cancer patients: A cross-sectional survey.
Reynolds LM, Barnett B, Weleff J, Morunga E, Wells A, Stack A, Akroyd A, Hoeh N, Sundram F, Muthukumaraswamy S, Lawrence N, Evans WJ. Reynolds LM, et al. Among authors: evans wj. Palliat Support Care. 2024 Aug;22(4):664-673. doi: 10.1017/S1478951522001481. Palliat Support Care. 2024. PMID: 36325995
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial.
Murphy RJ, Sumner R, Evans W, Ponton R, Ram S, Godfrey K, Forsyth A, Cavadino A, Krishnamurthy Naga V, Smith T, Hoeh NR, Menkes DB, Muthukumaraswamy S. Murphy RJ, et al. Biol Psychiatry. 2023 Sep 15;94(6):511-521. doi: 10.1016/j.biopsych.2023.03.013. Epub 2023 Mar 28. Biol Psychiatry. 2023. PMID: 36997080 Free article. Clinical Trial.
An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).
Donegan CJ, Daldegan-Bueno D, Sumner R, Menkes D, Evans W, Hoeh N, Sundram F, Reynolds L, Ponton R, Cavadino A, Smith T, Roop P, Allen N, Abeysinghe B, Svirskis D, Forsyth A, Bansal M, Muthukumaraswamy S. Donegan CJ, et al. Pilot Feasibility Stud. 2023 Oct 5;9(1):169. doi: 10.1186/s40814-023-01399-8. Pilot Feasibility Stud. 2023. PMID: 37798662 Free PMC article.
PAM trial protocol: a randomised feasibility study of psychedelic microdosing-assisted meaning-centred psychotherapy in advanced stage cancer patients.
Wells A, Muthukumaraswamy APS, Morunga E, Evans W, Cavadino A, Bansal M, Lawrence NJ, Ashley A, Hoeh NR, Sundram F, Applebaum AJ, Parkinson H, Reynolds L. Wells A, et al. Pilot Feasibility Stud. 2024 Feb 12;10(1):29. doi: 10.1186/s40814-024-01449-9. Pilot Feasibility Stud. 2024. PMID: 38347582 Free PMC article.
LSD increases sleep duration the night after microdosing.
Allen N, Jeremiah A, Murphy R, Sumner R, Forsyth A, Hoeh N, Menkes DB, Evans W, Muthukumaraswamy S, Sundram F, Roop P. Allen N, et al. Transl Psychiatry. 2024 Apr 15;14(1):191. doi: 10.1038/s41398-024-02900-4. Transl Psychiatry. 2024. PMID: 38622150 Free PMC article. Clinical Trial.
LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.
Daldegan-Bueno D, Donegan CJ, Forsyth A, Sumner RL, Murphy RJ, Menkes DB, Evans W, Hoeh N, Sundram F, Reynolds LM, Ponton R, Cavadino A, Smith T, Roop P, Allen N, Abeysinghe B, Svirskis D, Bansal M, Muthukumaraswamy S. Daldegan-Bueno D, et al. Trials. 2024 Aug 24;25(1):560. doi: 10.1186/s13063-024-08384-3. Trials. 2024. PMID: 39182140 Free PMC article.
575 results